1-161589676-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The ENST00000466542.6(FCGR2C):c.248C>A(p.Pro83Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 8/9 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0041 ( 21 hom., cov: 29)
Exomes 𝑓: 0.0026 ( 872 hom. )
Failed GnomAD Quality Control
Consequence
FCGR2C
ENST00000466542.6 missense
ENST00000466542.6 missense
Scores
7
Clinical Significance
Conservation
PhyloP100: -0.608
Genes affected
FCGR2C (HGNC:15626): (Fc gamma receptor IIc (gene/pseudogene)) This gene encodes one of three members of a family of low-affinity immunoglobulin gamma Fc receptors found on the surface of many immune response cells. The encoded protein is a transmembrane glycoprotein and may be involved in phagocytosis and clearing of immune complexes. An allelic polymorphism in this gene results in both coding and non-coding variants. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.018492132).
BP6
Variant 1-161589676-C-A is Benign according to our data. Variant chr1-161589676-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 2397613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCGR2C | NR_047648.1 | n.347C>A | non_coding_transcript_exon_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCGR2C | ENST00000466542.6 | c.248C>A | p.Pro83Gln | missense_variant | 3/7 | 1 | ENSP00000426627.1 | |||
ENSG00000289768 | ENST00000699402.1 | c.41-40645G>T | intron_variant | ENSP00000514363.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 595AN: 143550Hom.: 23 Cov.: 29 FAILED QC
GnomAD3 genomes
AF:
AC:
595
AN:
143550
Hom.:
Cov.:
29
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00162 AC: 392AN: 242532Hom.: 125 AF XY: 0.00154 AC XY: 202AN XY: 130912
GnomAD3 exomes
AF:
AC:
392
AN:
242532
Hom.:
AF XY:
AC XY:
202
AN XY:
130912
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00260 AC: 3650AN: 1404860Hom.: 872 Cov.: 37 AF XY: 0.00266 AC XY: 1856AN XY: 698456
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
3650
AN:
1404860
Hom.:
Cov.:
37
AF XY:
AC XY:
1856
AN XY:
698456
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00411 AC: 591AN: 143664Hom.: 21 Cov.: 29 AF XY: 0.00385 AC XY: 269AN XY: 69926
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
591
AN:
143664
Hom.:
Cov.:
29
AF XY:
AC XY:
269
AN XY:
69926
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
TwinsUK
AF:
AC:
40
ALSPAC
AF:
AC:
37
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
194
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | FCGR2C: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
Vest4
MVP
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at